Insider Trading Alert - WDAY, TIPT And MDT Traded By Insiders

Stocks with insider trader activity include WDAY, TIPT and MDT
By TheStreet Wire ,

Yesterday, July 19, 2016, 36 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $39.90 to $2,023,500.00.

Highlighted Stocks Traded by Insiders:

Workday (WDAY) - FREE Research Report

Peek Mark S, who is co-President at Workday, sold 6,904 shares at $79.05 on July 19, 2016. Following this transaction, the co-President owned 267,810 shares meaning that the stake was reduced by 2.51% with the 6,904-share transaction.

Bhusri Aneel, who is Chief Executive Officer at Workday, sold 10,353 shares at $79.06 on July 19, 2016. Following this transaction, the Chief Executive Officer owned 317,927 shares meaning that the stake was reduced by 3.15% with the 10,353-share transaction.

Sisco Robynne, who is Chief Financial Officer at Workday, sold 897 shares at $79.01 on July 19, 2016. Following this transaction, the Chief Financial Officer owned 93,900 shares meaning that the stake was reduced by 0.95% with the 897-share transaction.

Stankey Michael A., who is Vice Chairman at Workday, sold 8,781 shares at $79.06 on July 19, 2016. Following this transaction, the Vice Chairman owned 253,545 shares meaning that the stake was reduced by 3.35% with the 8,781-share transaction.

The shares most recently traded at $79.57, up $0.51, or 0.64% since the insider transaction. Historical insider transactions for Workday go as follows:

  • 4-Week # shares sold: 53,976
  • 12-Week # shares sold: 83,858
  • 24-Week # shares sold: 158,190

The average volume for Workday has been 1.7 million shares per day over the past 30 days. Workday has a market cap of $15.4 billion and is part of the technology sector and computer software & services industry. Shares are down 0.9% year-to-date as of the close of trading on Tuesday.

Workday, Inc. provides enterprise cloud applications for finance and human resources in the United States and internationally. It offers applications for customers to manage critical business functions that enable them to optimize their financial and human capital resources. Currently, there are 19 analysts who rate Workday a buy, 3 analysts rate it a sell, and 17 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WDAY - FREE

TheStreet Quant Ratings

rates Workday as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Workday Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 5,000 shares at $5.82 on July 19, 2016. Following this transaction, the Executive Chairman owned 3.6 million shares meaning that the stake was boosted by 0.14% with the 5,000-share transaction.

The shares most recently traded at $5.75, down $0.07, or 1.14% since the insider transaction. Historical insider transactions for Tiptree Financial go as follows:

  • 4-Week # shares bought: 37,913
  • 4-Week # shares sold: 3,500
  • 12-Week # shares bought: 95,841
  • 12-Week # shares sold: 3,500
  • 24-Week # shares bought: 213,614
  • 24-Week # shares sold: 43,121

The average volume for Tiptree Financial has been 35,900 shares per day over the past 30 days. Tiptree Financial has a market cap of $243.5 million and is part of the financial sector and insurance industry. Shares are down 7.33% year-to-date as of the close of trading on Tuesday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt. The stock currently has a dividend yield of 1.76%.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings

rates Tiptree Financial as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, poor profit margins and generally disappointing historical performance in the stock itself. Get the full

Tiptree Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medtronic (MDT) - FREE Research Report

Martha Geoffrey, who is EVP & GroupPres Restora Therap at Medtronic, sold 3,766 shares at $88.26 on July 19, 2016. Following this transaction, the EVP & GroupPres Restora Therap owned 26,273 shares meaning that the stake was reduced by 12.54% with the 3,766-share transaction.

The shares most recently traded at $88.80, up $0.54, or 0.6% since the insider transaction. Historical insider transactions for Medtronic go as follows:

  • 4-Week # shares sold: 9,787
  • 12-Week # shares sold: 11,471
  • 24-Week # shares sold: 49,270

The average volume for Medtronic has been 5.2 million shares per day over the past 30 days. Medtronic has a market cap of $123.0 billion and is part of the health care sector and health services industry. Shares are up 14.9% year-to-date as of the close of trading on Tuesday.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The stock currently has a dividend yield of 1.95%. The company has a P/E ratio of 35.6. Currently, there are 14 analysts who rate Medtronic a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDT - FREE

TheStreet Quant Ratings

rates Medtronic as a

buy

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and reasonable valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Medtronic Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...